Showing results (31-40 of 120) with videos related to
Sort By:
Pageof 12
The Journal of Clinical Investigation|May 1, 1992
Cysteamine enhances the procoagulant activity of Factor VIII-East Hartford, a dysfunctional protein due to a light chain thrombin cleavage site mutation (arginine-1689 to cysteine)A M Aly, M Arai, L W HoyerBlood|March 1, 1982
Distribution of plasma fibronectin (cold-insoluble globulin) and components of the factor VIII complex after heparin-induced precipitation of plasmaD L Amrani, M W Mosesson, L W HoyerProceedings of the National Academy of Sciences of the United States of America|May 1, 1974
Synthesis of von Willebrand factor by cultured human endothelial cellsE A Jaffe, L W Hoyer, R L NachmanThe Journal of Clinical Investigation|November 1, 1973
Synthesis of antihemophilic factor antigen by cultured human endothelial cellsE A Jaffe, L W Hoyer, R L NachmanBlood|September 15, 1995
Immunoblot cross-reactivity of factor VIII inhibitors with porcine factor VIIIK Koshihara, J Qian, P Lollar, et al.The Journal of Clinical Investigation|May 1, 1974
Immunofluorescent localization of antihemophilic factor antigen and fibrinogen in human renal diseasesJ R Hoyer, A F Michael, L W HoyerThe Journal of Clinical Investigation|August 1, 1977
Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's diseaseH J Weiss, I I Sussman, L W HoyerBritish Journal of Haematology|January 1, 1985
The effect of 1-deamino 8 D-arginine vasopressin (DDAVP) in a nonhaemophilic patient with an acquired type II factor VIII inhibitorB de la Fuente, S Panek, L W HoyerBlood|December 1, 1982
Detection of hemophilia carriers during pregnancyL W Hoyer, C A Carta, M J MahoneyProgress in Clinical and Biological Research|January 1, 1984
Immunochemical characterization of factor VIII inhibitorsL W Hoyer, M S Gawryl, B de la FuentePageof 12